Skip to content

PolitiKit

Sridhar Venkatesh's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Sridhar Venkatesh

General Manager and President

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
45
Since Nov 2021
145
Active registrations
0

Reported meetings

  • GlaxoSmithKline Inc.
    • Stephen Ellis · Member of Parliament, House of Commons
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy Read more

    Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Melissa Sutherland · Director General, Health Canada (HC)
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy Read more

    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Erin Henry · Director General, Public Health Agency of Canada (PHAC)
    • Matthew Tunis · Executive Secretary, Public Health Agency of Canada (PHAC)
    • Heather Deehan · Director, Public Health Agency of Canada (PHAC)
    • Michael Pignat · Manager, Procurement, Public Health Agency of Canada (PHAC)
    Trade-related matters, including policies and tariffs impacting medicines and vaccines. Read more

    National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
    Trade-related matters, including policies and tariffs impacting medicines and vaccines. Read more

    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Eric Nicol · Director of Policy, Employment and Social Development Canada (ESDC)
    National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Read more

    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White · Director, Innovation, Science and Economic Development Canada (ISED)
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy Read more

    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Official report

  • GlaxoSmithKline Inc.
    • François-Philippe Champagne · Minister, Innovation, Science and Economic Development Canada (ISED)
    • Laurel Chester · Sr Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy Read more

    Engagement with the Government regarding the Strategic Innovation Fund

    Official report

  • GlaxoSmithKline Inc.
    • Erin Henry · Director General, Public Health Agency of Canada (PHAC)
    • Jacqueline Kosche · Director, Vaccine Logistics and Operations, Public Health Agency of Canada (PHAC)
    • Natalie Gravelle · A/ Director, Public Health Agency of Canada (PHAC)
    National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Mohamed-Iqbal Ravalia · Senator, Senate of Canada
    National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada. Read more

    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR.

    Official report

  • GlaxoSmithKline Inc.
    • Greg Orencsak · Deputy Minister, Health Canada (HC)
    • Jill Norman · Director, Health Canada (HC)
    • Amanda Ratz · Senior Advisor, Health Canada (HC)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Read more

    Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030.

    National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Mark Holland · Minister of Health, Health Canada (HC)
    • Eshan Naik · Director of Policy, Health Canada (HC)
    Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Read more

    National Immunization Strategy. Advocacy to seek continued investment in vaccines funding and an overall strategy for prevention of disease in Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Jean-Yves Duclos · Member of Parliament
    • Loic Pare · Regional Affairs Advisor, Public Services and Procurement Canada (PSPC)
    Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Heather Earle · Manager, Innovation, Science and Economic Development Canada (ISED)
    • Bryan Dalphy · Deputy Director, Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White · Director, Innovation, Science and Economic Development Canada (ISED)
    and 1 more
    • Simon Young · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Jacqueline Arthur · Director, innovative Supply Solutions: AMR, CVTR, Public Health Agency of Canada (PHAC)
    • Niyi Lawuyi · Manager of Supply Access and Logistics, Public Health Agency of Canada (PHAC)
    • Christina Surujballi · Senior Policy Analyst, Public Health Agency of Canada (PHAC)
    • Bronwen Clark-Brewin · Policy Analyst, Public Health Agency of Canada (PHAC)
    and 4 more
    • Joshua Atkinson · Project Manager, Public Health Agency of Canada (PHAC)
    • Dylan Kovacs · Policy analyst, Public Health Agency of Canada (PHAC)
    • Nesreen Mandanas · Policy Analyst, Public Health Agency of Canada (PHAC)
    • Kathleen Dunn · Senior advisor, Public Health Agency of Canada (PHAC)
    Antimicrobial Resistance (AMR) - Identification of the need for a multi-sectoral stakeholder working group to pursue joint goals under a Pan-Canadian AMR strategy and to strengthen Canada's end-to-end research capacity in AMR. Read more

    Official report

  • GlaxoSmithKline Inc.
    • Greg Orencsak · Deputy Minister, Health Canada (HC)
    • Michelle Boudreau · Executive Director, Health Canada (HC)
    • Melissa Sutherland · A/ Director General, Health Canada (HC)
    Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy Read more

    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Engagement with federal officials regarding Health Emergency Readiness Canada.

    Official report

  • GlaxoSmithKline Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White · Director, Innovation, Science and Economic Development Canada (ISED)
    • Bryan Dalphy · Deputy Director, Innovation, Science and Economic Development Canada (ISED)

    Economic DevelopmentHealth

    Official report

  • GlaxoSmithKline Inc.

    Economic DevelopmentHealth

    Official report

  • GlaxoSmithKline Inc.
    • Mohamed-Iqbal Ravalia · Senator, Senate of Canada

    Health

    Official report

  • GlaxoSmithKline Inc.

    Health

    Official report

  • GlaxoSmithKline Inc.
    • Joel Denis · Director General, Public Health Agency of Canada (PHAC)
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    • Greg Orencsak · Deputy Minister, Health Canada (HC)
    • Eric Costen · Associate Deputy Minister, Health Canada (HC)

    Economic DevelopmentHealthResearch and Development

    Official report

  • GlaxoSmithKline Inc.
    • Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)

    Health

    Official report

  • GlaxoSmithKline Inc.
    • Joel Denis · Director General, Public Health Agency of Canada (PHAC)
    • Erin Henry · Director General, Public Health Agency of Canada (PHAC)
    • Jacqueline Kosche · Director, Public Health Agency of Canada (PHAC)
    • Christina Jensen · Manager, Canadian Immunization Guide, Public Health Agency of Canada (PHAC)

    Health

    Official report

  • GlaxoSmithKline Inc.
    • Eshan Naik · Director of Policy, Health Canada (HC)

    Health

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.